TransMedics (TMDX) is a publicly traded Healthcare sector company. As of August 25, 2026, TMDX trades at $93.25 with a market cap of $3.29B and a P/E ratio of 21.04. TMDX moved -1.25% today. Year to date, TMDX is -23.06%; over the trailing twelve months it is -21.90%. Its 52-week range spans $55.00 to $156.00. Analyst consensus is buy with an average price target of $94.22. Rallies surfaces TMDX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
TransMedics (TMDX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. TMDX moved -1.25% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $93.25 |
| Market Cap | $3.29B |
| P/E Ratio | 21.04 |
| EPS | $4.44 |
| Dividend Yield | 0.00% |
| 52-Week High | $156.00 |
| 52-Week Low | $55.00 |
| Volume | 652.80K |
| Avg Volume | 0 |
| Revenue (TTM) | $668.47M |
| Net Income | $151.70M |
| Gross Margin | 58.69% |
10 analysts cover TMDX: 0 strong buy, 7 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $94.22.